SCHEMBL14035933

SCHEMBL14035933

COc1ccc(-c2[nH]c3cc(C(=O)OC(C)(C)C)ccc3c2C2CCCCC2)c(C)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
GABRA1 P14867 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA3 P34903 1/20 0.36
GABRA2 P47869 1/20 0.36
MAPKAPK2 P49137 1/20 0.35
MAPKAPK5 Q8IW41 1/20 0.35
MTNR1A P48039 1/20 0.35
MTNR1B P49286 1/20 0.35
HSD11B1 P28845 1/20 0.35
TRPV1 Q8NER1 1/20 0.35
PARP1 P09874 1/20 0.35
TP53 P04637 1/20 0.35
KIF11 P52732 1/20 0.34
MAPT P10636 3/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14074220 0.91 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2MEN1KMT2AGABRA1
SCHEMBL12653139 0.89 MTNR1A (0.36) ALDH1A1SMN1; SMN2MEN1KMT2AGABRA1
SCHEMBL54971 0.89 ALDH1A1 (0.35) ALDH1A1SMN1; SMN2MEN1KMT2AGABRA1
SCHEMBL19316391 0.82 GABRA1 (0.44) ALDH1A1SMN1; SMN2MEN1KMT2AGABRA1
SCHEMBL2279943 0.82 PARP1 (0.45) ALDH1A1SMN1; SMN2MEN1KMT2AMAPKAPK2
SCHEMBL13188690 0.80 NR1I2 (0.51) ALDH1A1SMN1; SMN2MEN1KMT2ATRPV1
SCHEMBL2907936 0.80 HTR2A (0.44) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL12620167 0.79 HTR2A (0.37) SMN1; SMN2GABRA1GABRG2GABRB3GABRA3
SCHEMBL12620158 0.79 HTR2A (0.37) GABRA1GABRG2GABRB3GABRA3GABRA2
SCHEMBL10293516 0.79 GABRA1 (0.43) ALDH1A1SMN1; SMN2MEN1KMT2AGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7456166-B2 Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2008-11-25 US disclosed